KLS-13023

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameKLS-13023
Drug Alias NameKLS-13023
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor inverse agonistsCannabinoid CB1 receptor inverse agonists
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptor
Therapy Area/IndicationsBrain Injuries, TraumaticHepatic Encephalopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuropathix Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuropathix Inc
Inactive CompaniesN/A
Active IndicationsBrain Injuries, TraumaticHepatic Encephalopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A